Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|168|6|771-783

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.168, Iss.6, 2015-03, pp. : 771-783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cutaneous involvement in systemic anaplastic large cell lymphoma

By  

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 13, Iss. 7, 2015-07 ,pp. : 693-694

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 4, 2018-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features

By  

HISTOPATHOLOGY, Vol. 66, Iss. 6, 2015-05 ,pp. : 846-855

John Wiley & Sons Inc

Access to resources Recommend Favorite

Secondary cutaneous involvement by systemic anaplastic lymphoma kinase‐negative anaplastic large‐cell lymphoma with 6p25.3 rearrangement

By  

HISTOPATHOLOGY, Vol. 67, Iss. 6, 2015-12 ,pp. : 932-935

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of High-Risk Peripheral T-Cell Lymphomas other than Anaplastic Large-Cell Lymphoma with a Dose-Intensified CHOP Regimen Followed by High-Dose Chemotherapy

By  

Acta Haematologica, Vol. 116, Iss. 2, 2006-08 ,pp. : 90-95

Karger

Access to resources Recommend Favorite